Advertisement

Topics

Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

20:00 EDT 15 Apr 2019 | Arthritis Research and Therapy

Following publication of the original article [1], the authors reported an error in Table 2.

Original Article: Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan

NEXT ARTICLE

More From BioPortfolio on "Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan"

Advertisement
Quick Search
Advertisement
Advertisement